| |
| |
|
| Insider
Information: |
Mollica Joseph A |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
262,182 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,621,155 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,182 |
|
|
| Total
Value |
$7,621,155 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Accelrys Inc |
ACCL |
Chairman, President an... |
2004-04-30 |
170,900 |
2003-06-30 |
0 |
Premium* |
|
|
Redpoint Bio Corp |
RPBC |
Director |
2007-12-19 |
35,240 |
|
0 |
Premium* |
|
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2017-04-12 |
56,042 |
2013-03-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-04-12 |
4 |
D |
$51.80 |
$67,962 |
D/D |
(1,312) |
56,042 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2017-04-12 |
4 |
OE |
$3.40 |
$68,000 |
D/D |
20,000 |
57,354 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-02-10 |
4 |
D |
$33.70 |
$61,368 |
D/D |
(1,821) |
37,354 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2016-02-10 |
4 |
OE |
$3.07 |
$61,400 |
D/D |
20,000 |
39,175 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2014-12-12 |
4 |
D |
$21.97 |
$95,196 |
D/D |
(4,333) |
19,175 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2014-12-12 |
4 |
OE |
$4.76 |
$95,200 |
D/D |
20,000 |
23,508 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2014-04-16 |
4 |
D |
$13.84 |
$185,539 |
D/D |
(13,406) |
3,508 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2014-04-16 |
4 |
OE |
$12.37 |
$185,550 |
D/D |
15,000 |
16,914 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2013-03-28 |
4 |
OE |
$10.60 |
$159,000 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Director |
– • – |
2013-03-28 |
4 |
D |
$12.15 |
$158,995 |
D/D |
(13,086) |
1,914 |
0 |
- |
|
| RPBC |
Redpoint Bio Corp |
Director |
– • – |
2007-12-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,240 |
|
- |
|
| ACCL |
Accelrys Inc |
Chairman, President and CEO |
• • – |
2004-04-30 |
4 |
A |
$17.93 |
$1,325 |
D/D |
74 |
170,901 |
|
- |
|
| ACCL |
Accelrys Inc |
Chairman, President and CEO |
• • – |
2004-03-31 |
4 |
A |
$20.12 |
$1,325 |
D/D |
66 |
170,827 |
|
- |
|
| ACCL |
Accelrys Inc |
Chairman, President and CEO |
• • – |
2004-02-27 |
4 |
A |
$19.50 |
$1,325 |
D/D |
68 |
165,061 |
|
- |
|
| ACCL |
Accelrys Inc |
Chairman, President and CEO |
• • – |
2004-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,700 |
170,693 |
|
- |
|
| ACCL |
Accelrys Inc |
Chairman, President and CEO |
• • – |
2004-01-30 |
4 |
A |
$19.87 |
$1,325 |
D/D |
67 |
164,993 |
|
- |
|
| ACCL |
Accelrys Inc |
Chairman, President and CEO |
• • – |
2003-06-30 |
4 |
A |
$8.25 |
$1,000 |
D/D |
121 |
164,926 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
